scispace - formally typeset
A

Ashutosh Shandilya

Researcher at Indian Institute of Technology Delhi

Publications -  26
Citations -  868

Ashutosh Shandilya is an academic researcher from Indian Institute of Technology Delhi. The author has contributed to research in topics: Docking (molecular) & CDC37. The author has an hindex of 15, co-authored 24 publications receiving 754 citations. Previous affiliations of Ashutosh Shandilya include Indian Institutes of Technology.

Papers
More filters
Journal ArticleDOI

Inhibition of the NEMO/IKKβ association complex formation, a novel mechanism associated with the NF-κB activation suppression by Withania somnifera’s key metabolite withaferin A

TL;DR: This study attempts to explore NF-κB signalling pathway modulating capability of Withania somnifera’s major constituent WA and to elucidate its possible mode of action using molecular docking and molecular dynamics simulations studies.
Journal ArticleDOI

A plausible mechanism for the antimalarial activity of artemisinin: A computational approach

TL;DR: Results suggest that artemisinin gets activated by iron which in turn inhibits PfATP6 by closing the phosphorylation, nucleotide binding and actuator domains leading to loss of function of PfATp6 of the parasite and its death.
Journal ArticleDOI

Hsp90/Cdc37 Chaperone/co-chaperone complex, a novel junction anticancer target elucidated by the mode of action of herbal drug Withaferin A

TL;DR: The study conducted here is an attempt to explore the potential of Withania somnifera’s major constituent WA (Withaferin A) in attenuating the Hsp90/Cdc37 chaperone/co-chaperone interactions for enhanced tumor arresting activity and to elucidate the underlying mode of action using computational approaches.
Journal ArticleDOI

Curcumin specifically binds to the human calcium–calmodulin-dependent protein kinase IV: fluorescence and molecular dynamics simulation studies

TL;DR: In insights into designing a new inspired curcumin derivatives as therapeutic agents against many life-threatening diseases, the interaction ofCurcumin with human CAMK4 is studied using molecular docking, molecular dynamics simulations, fluorescence binding, and surface plasmon resonance (SPR) methods.
Journal ArticleDOI

Withanone binds to mortalin and abrogates mortalin-p53 complex: computational and experimental evidence.

TL;DR: A molecular interaction basis that could be used for screening and development of anticancer drugs with low toxicity to normal cells is established and accurate knowledge of the 3D structure of mortalin would further enhance the potential of such analyses to understand the molecular basis ofmortalin biology and mortalin based cancer therapy.